Yngvild S Danielsen1, Inger H Nordhus2, Petur B Júlíusson3, Magne Mæhle4, Ståle Pallesen2. 1. Faculty of Psychology, University of Bergen, Cristiesgt. 12, NO-5020 Bergen, Norway. Electronic address:yngvild.danielsen@psysp.uib.no. 2. Norwegian Competence Centre for Sleep Disorders, Haukeland University Hospital, Bergen, Norway. 3. Section of Paediatrics, Department of Clinical Medicine, University of Bergen, Haukeland University Hospital, Bergen, Norway. 4. Sogn og Fjordane University College, Sogndal, Norway.
Abstract
OBJECTIVE: We examined the effect of a 12-week family-based cognitive behavioural weight management programme developed for use in primary care settings. METHODS: The sample consisted of 49 children with obesity (aged 7-13 years; mean ± SD: 10.68 ± 1.24). Families were randomly assigned to immediate start-up of treatment or to a 12-week waiting list condition. Outcome measures were body mass index standard deviation score (BMI SDS), self-esteem, symptoms of depression and blood parameters indicative of cardio-metabolic risk. Assessments were conducted at baseline, post-treatment, post-waiting list and 12 months after treatment termination. RESULTS: The mean reduction for the treatment group was -0.16 BMI SDS units compared with an increase of 0.04 units for the waiting list group (p = .001). For the entire sample, there was a significant post-treatment improvement on BMI SDS (p = .001), all self-esteem measures (p = .001-.041) and symptoms of depression (p = .004). The mean BMI SDS reduction was -0.18 units post-treatment, and it was maintained at 12-month follow-up. Significant reductions were found in blood lipid levels of total cholesterol (p = .03), LDL-cholesterol (p = .005) and HDL-cholesterol (p = .01) at 12-month follow-up. The favourable effect on most of the psychological measures waned from post-treatment to follow-up, but not approaching baseline levels. Boys demonstrated significantly greater reductions in BMI SDS than girls (p = .001), while baseline psychiatric co-morbidity did not influence BMI SDS outcome. CONCLUSIONS: The treatment shows significant and favourable effects on BMI SDS, self-esteem and symptoms of depression compared with a waiting list condition. Â
RCT Entities:
OBJECTIVE: We examined the effect of a 12-week family-based cognitive behavioural weight management programme developed for use in primary care settings. METHODS: The sample consisted of 49 children with obesity (aged 7-13 years; mean ± SD: 10.68 ± 1.24). Families were randomly assigned to immediate start-up of treatment or to a 12-week waiting list condition. Outcome measures were body mass index standard deviation score (BMI SDS), self-esteem, symptoms of depression and blood parameters indicative of cardio-metabolic risk. Assessments were conducted at baseline, post-treatment, post-waiting list and 12 months after treatment termination. RESULTS: The mean reduction for the treatment group was -0.16 BMI SDS units compared with an increase of 0.04 units for the waiting list group (p = .001). For the entire sample, there was a significant post-treatment improvement on BMI SDS (p = .001), all self-esteem measures (p = .001-.041) and symptoms of depression (p = .004). The mean BMI SDS reduction was -0.18 units post-treatment, and it was maintained at 12-month follow-up. Significant reductions were found in blood lipid levels of total cholesterol (p = .03), LDL-cholesterol (p = .005) and HDL-cholesterol (p = .01) at 12-month follow-up. The favourable effect on most of the psychological measures waned from post-treatment to follow-up, but not approaching baseline levels. Boys demonstrated significantly greater reductions in BMI SDS than girls (p = .001), while baseline psychiatric co-morbidity did not influence BMI SDS outcome. CONCLUSIONS: The treatment shows significant and favourable effects on BMI SDS, self-esteem and symptoms of depression compared with a waiting list condition. Â
Authors: J H Taylor; Y Xu; F Li; M Shaw; J Dziura; S Caprio; W V Tamborlane; P Nowicka; M Savoye Journal: Pediatr Obes Date: 2016-07-07 Impact factor: 4.000
Authors: Hanna F Skjåkødegård; Yngvild S Danielsen; Mette Morken; Sara-Rebekka F Linde; Rachel P Kolko; Katherine N Balantekin; Denise E Wilfley; Pétur B Júlíusson Journal: BMC Public Health Date: 2016-10-21 Impact factor: 3.295
Authors: Emma Mead; Tamara Brown; Karen Rees; Liane B Azevedo; Victoria Whittaker; Dan Jones; Joan Olajide; Giulia M Mainardi; Eva Corpeleijn; Claire O'Malley; Elizabeth Beardsmore; Lena Al-Khudairy; Louise Baur; Maria-Inti Metzendorf; Alessandro Demaio; Louisa J Ells Journal: Cochrane Database Syst Rev Date: 2017-06-22